William Charles Schumann Has An Investor Complaint – Goodman & Nekvasil, P.A. May Recover Investor Losses
CETERA INVESTMENT ADVISERS LLC investment adviser, William Charles Schumann has an investor complaint.
CRD#: 1604894
Call 800-500-4442 if you think that you have received unsuitable investment recommendations from your adviser.
William Charles Schumann (CRD#: 1604894), a registered representative for CETERA FINANCIAL SPECIALISTS LLC in WHEATON, IL, has an investor complaint. According to Schumann’s FINRA BrokerCheck report, The Statement of Claim was filed on behalf of nine claimants against Grove Point Investments, LLC involving the same investment – NorthStar Healthcare Income REIT. Claimants allege unsuitability, overconcentration, breach of fiduciary duty and negligence. Activity occurred March 24, 2014 to February 12, 2016.
The customers are requesting $300,000.00 for alleged damages.
William Charles Schumann has an investor complaint.
Goodman & Nekvasil, P.A., is investigating brokers who may have unsuitably recommended investments to their clients.
St. Petersburg, Florida law firm Goodman & Nekvasil, P.A., has a national practice representing victimized investors. The firm continues to investigate brokerage firms that placed elderly retirees and other conservative investors in unsuitable investments.
Goodman & Nekvasil, P.A., has filed numerous cases against brokerage firms selling high-risk investments and has recovered more than $400 million dollars on behalf of victimized investors.
We allege in these cases that these investment recommendations were unsuitable for our clients in view of their financial situation, needs and investment objectives.
There is no charge for an evaluation of your case. We handle our cases on a contingency fee basis. This means that unless we recover money for you, we charge no attorney’s fee.
If you incurred losses on your investment and would like your case evaluated by a securities attorney, please contact us.
Some of the information in this blog post was obtained from FINRA on 11/19/24. If you believe this information was reported incorrectly, please contact our firm: 1-800-500-4442.